Eden Health GLP-1 vs Zealthy

Recorded prices, access and terms.

Decision table

The entries below are recorded provider statements unless a regulatory source is linked. A provider webpage does not independently verify its licenses or quality. Eden Health GLP-1 source · Zealthy source.

CompareEden Health GLP-1Zealthy
Recorded medication/program subtotalMonthly-plan rate unconfirmed. Advertised headline prices may require prepayment, a specific dose or introductory terms. Full required cost is unconfirmed.Monthly-plan rate unconfirmed. Advertised headline prices may require prepayment, a specific dose or introductory terms. Full required cost is unconfirmed.
Full required monthly costUnconfirmed: consultation, labs, membership, dose changes and shipping must be checkedUnconfirmed: consultation, labs, membership, dose changes and shipping must be checked
Drug type listedBrand-name and compoundedBrand-name and compounded
ConsultationIncluded in the record; current conditions unconfirmed$135/mo membership in the record; current conditions unconfirmed
Pharmacy licenseNot independently verified. Obtain the dispensing pharmacy name and verify its state license.Not independently verified. Obtain the dispensing pharmacy name and verify its state license.
Reported states50; confirm eligibility and clinician licensing in your state50; confirm eligibility and clinician licensing in your state
CancellationCancellation reported; notice, minimum term and refund conditions unconfirmedCancellation reported; notice, minimum term and refund conditions unconfirmed
Clinician/support as reportedBoard-certified physicians, lab monitoringLicensed physicians, ongoing clinical support
Recorded provider checkNo date recordedNo date recorded

Which should you choose?

Ask each provider for the full cost at your prescribed dose, required labs and visits, the dispensing pharmacy, the clinician's state license, renewal charges and written refund terms. Compare those answers with your clinician.

Compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness or quality before marketing. FDA source and recommendations.

Eden Health GLP-1: evidence and terms

Recorded FDA letter (2026-06-08): FDA reviewed tryeden.com in March 2026 and found its claims for compounded semaglutide and tirzepatide false or misleading, making the products misbranded under FD&C Act sections 502(a) and 502(bb). One of fifteen telehealth firms warned the same day. FDA letter.

Read Eden Health GLP-1's sourced record · Eden Health GLP-1 source

Zealthy: evidence and terms

Recorded FDA letter (2025-09-09): FDA found claims on getzealthy.com for compounded GLP-1 products false or misleading, making the products misbranded under FD&C Act sections 502(a) and 502(bb). FDA letter.

Read Zealthy's sourced record · Zealthy source

Compare the full provider directory · Compare recorded price subtotals

Compare providersVisit Embody →